Comparing machine learning and deep learning models to predict cognition progression in Parkinson's disease

被引:0
|
作者
Bernal, Edgar A. [1 ]
Yang, Shu [2 ,3 ]
Herbst, Konnor [2 ]
Venuto, Charles S. [2 ,4 ]
机构
[1] FLX AI, Rochester, NY USA
[2] Univ Rochester, Ctr Hlth Technol, 265 Crittenden Blvd, Rochester, NY 14642 USA
[3] Univ Rochester, Hajim Sch Engn & Appl Sci, Rochester, NY USA
[4] Univ Rochester, Dept Neurol, Rochester, NY USA
来源
关键词
QUALITY-OF-LIFE; DIAGNOSTIC-CRITERIA; IMPAIRMENT; DEMENTIA; BIOMARKERS; DECLINE; FUSION;
D O I
10.1111/cts.70066
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cognitive decline in Parkinson's disease (PD) varies widely. While models to predict cognitive progression exist, comparing traditional probabilistic models to deep learning methods remains understudied. This study compares sequential modeling techniques to identify cognitive progression in individuals with and without PD. Using data from the Parkinson's Progression Marker Initiative, shallow Markov, deep recurrent (long short-term memory [LSTM]), and nonrecurrent (temporal fusion transformer [TFT]) models were compared to predict cognitive status over time. Cognitive status was categorized into normal cognition (NC), mild cognitive impairment (MCI), and dementia. Predictions were made annually for up to 3 years using clinical data, including demographics, cognitive assessments, PD severity, and medical history. Each approach was evaluated using inverse probability weighted (IPW-) F1 scores. An ensemble method combined outputs from the Markov, LSTM, and TFT models. The dataset included 917 individuals (53% PD; 30% at risk for PD; 17% Healthy Controls). The TFT model outperformed others across all annual periods (IPW-F1 = 0.468) compared to the Markov (IPW-F1 = 0.349) and LSTM (IPW-F1 = 0.414) models, with improved performance using an ensemble approach (IPW-F1 = 0.502). For MCI and dementia predictions, which were rarer occurrences compared to NC status (ratios: 50:8:1), the TFT model consistently outperformed competing models, achieving IPW-F1 scores of 0.496 and 0.533 for MCI and dementia, respectively. In conclusion, sequential deep learning models like TFT, which mitigate long-term memory loss and can interpret complex, high-dimensional data, perform best overall in predicting clinically important cognitive transitions. These methods should be further explored for predicting degenerative conditions.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Machine Learning Approaches in Parkinson's Disease
    Landolfi, Annamaria
    Ricciardi, Carlo
    Donisi, Leandro
    Cesarelli, Giuseppe
    Troisi, Jacopo
    Vitale, Carmine
    Barone, Paolo
    Amboni, Marianna
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (32) : 6548 - 6568
  • [22] Machine Learning Models for Parkinson Disease: Systematic Review
    Tabashum, Thasina
    Snyder, Robert Cooper
    O'Brien, Megan K.
    Albert, Mark, V
    JMIR MEDICAL INFORMATICS, 2024, 12
  • [23] Machine learning and deep learning for clinical data and PET/SPECT imaging in parkinson’s disease: A review
    Khachnaoui, Hajer
    Mabrouk, Rostom
    Khlifa, Nawres
    IET Image Processing, 2020, 14 (16):
  • [24] Machine learning and deep learning for clinical data and PET/SPECT imaging in Parkinson's disease: a review
    Khachnaoui, Hajer
    Mabrouk, Rostom
    Khlifa, Nawres
    IET IMAGE PROCESSING, 2020, 14 (16) : 4013 - 4026
  • [25] Creation of a Machine Learning Model to Predict Cognitive Outcomes Post Deep Brain Stimulation Surgery for Parkinson's Disease
    Deshpande, R.
    Haliasos, N.
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [26] A Machine Learning Approach to Predict Lymphangioleiomyomatosis Lung Disease Progression
    Huang, J.
    Xu, W.
    Cheng, C.
    Hu, D.
    Jamous, F. G.
    Wang, H.
    Xu, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [27] A machine learning approach to predict quality of life changes in patients with Parkinson's Disease
    Alexander, Tyler D.
    Nataraj, Chandrasekhar
    Wu, Chengyuan
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2023, 10 (03): : 312 - 320
  • [28] Predicting Parkinson's Disease Progression: Analyzing Prodromal Stages Through Machine Learning
    Martinez-Eguiluz, Maitane
    Muguerz, Javier
    Arbelaitz, Olatz
    Gurrutxaga, Ibai
    Carlos Gomez-Esteban, Juan
    Murueta-Goyena, Ane
    Gabilondo, Inigo
    ADVANCES IN ARTIFICIAL INTELLIGENCE, CAEPIA 2024, 2024, : 61 - 70
  • [29] Identification of motor progression in Parkinson’s disease using wearable sensors and machine learning
    Charalampos Sotirakis
    Zi Su
    Maksymilian A. Brzezicki
    Niall Conway
    Lionel Tarassenko
    James J. FitzGerald
    Chrystalina A. Antoniades
    npj Parkinson's Disease, 9
  • [30] Identification of motor progression in Parkinson's disease using wearable sensors and machine learning
    Sotirakis, Charalampos
    Su, Zi
    Brzezicki, Maksymilian A.
    Conway, Niall
    Tarassenko, Lionel
    Fitzgerald, James J.
    Antoniades, Chrystalina A.
    NPJ PARKINSONS DISEASE, 2023, 9 (01)